|
Volumn 130, Issue 4, 2010, Pages 521-526
|
Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis
|
Author keywords
Acetylcholinesterase inhibitor; Alzheimer's disease; Donepezil; Mulberry leaf extract; NMDA antagonist; amyloid
|
Indexed keywords
ALPHA SECRETASE;
AMYLOID BETA PROTEIN;
BETA SECRETASE INHIBITOR;
CHOLINESTERASE INHIBITOR;
CURCUMIN;
FLURBIPROFEN;
GAMMA SECRETASE INHIBITOR;
HOMOTAURINE;
IBUPROFEN;
LY 2434074;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NAPROXEN;
NATURAL PRODUCT;
NGX 267;
PLANT EXTRACT;
SULINDAC;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG STRUCTURE;
MULBERRY;
NEUROPROTECTION;
NEUROTOXICITY;
PROTEIN AGGREGATION;
REVIEW;
|
EID: 77950445765
PISSN: 00316903
EISSN: 13475231
Source Type: Journal
DOI: 10.1248/yakushi.130.521 Document Type: Review |
Times cited : (8)
|
References (8)
|